News

/News/

Immunovaccine Announces Closing of CAD$14,375,000 Bought Deal Offering with Over-Allotment Option Exercised in Full

By | March 6th, 2018|Bloom Burton, Financing, News|

HALIFAX, N.S., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. [...]

Canada in Science – March 2, 2018

By | March 2nd, 2018|Blog, Canada in Science|

Welcome to your Canada in Science Review for March 2nd, [...]

Big Pharma’s Drug War: Innovative vs. Generic and Biosimilar Drugs

By | February 16th, 2018|Beyond the Bench, Blog|

Big Pharma's Drug War: Innovative vs. Generic and Biosimilar Drugs [...]

Bloom Burton & Co. Announces the 2018 Bloom Burton Award Gala

By | February 12th, 2018|Bloom Burton, News|

Annual Award Recognizes the Most Significant Contributor to Canada’s Innovative [...]

Canada in Science – Feb 2, 2018

By | February 2nd, 2018|Blog, Canada in Science|

  Welcome to your Canada in Science Review for February [...]

Plasma for Profit: The Changing Landscape of Blood Donation

By | February 1st, 2018|Beyond the Bench, Blog|

Plasma for Profit: The Changing Landscape of Blood Donation By [...]

Q4 & Annual 2017 Share Price Performance – Part 3

By | January 25th, 2018|Analysis, Blog, Capital Markets|

            Tier 2 Canadian Healthcare [...]

Q4 & Annual 2017 Share Price Performance – Part 2

By | January 22nd, 2018|Analysis, Blog, Capital Markets|

              Tier 1 Canadian [...]

ESSA Completes US$26 Million Equity Offering

By | January 19th, 2018|Financing, News|

  Read the full press release here.

Paul Lammers, M.D., M.Sc. Joins Triumvira as President and Chief Executive Officer

By | January 18th, 2018|HR Changes, News|

Read the full press release here.